Cargando…

A pH-Sensitive Prodrug Nanocarrier Based on Diosgenin for Doxorubicin Delivery to Efficiently Inhibit Tumor Metastasis

BACKGROUND: The metastasis, one of the biggest barriers in cancer therapy, is the leading cause of tumor deterioration and recurrence. The anti.-metastasis has been considered as a feasible strategy for clinical cancer management. It is well known that diosgenin could inhibit tumor metastasis and do...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Zeliang, Wang, Haibo, Xin, Guang, Zeng, Zhi, Li, Shiyi, Ming, Yue, Zhang, Xiaoyu, Xing, Zhihua, Li, Li, Li, Youping, Zhang, Boli, Zhang, Junhua, Niu, Hai, Huang, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480473/ https://www.ncbi.nlm.nih.gov/pubmed/32943867 http://dx.doi.org/10.2147/IJN.S250549

Ejemplares similares

Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers
por: Jin, Yonglong, et al.
Publicado: (2020)

Drug D, a Diosgenin Derive, Inhibits L-Arginine-Induced Acute Pancreatitis through Meditating GSDMD in the Endoplasmic Reticulum via the TXNIP/HIF-1α Pathway
por: Zhang, Cuicui, et al.
Publicado: (2022)

Dual-targeted and pH-sensitive Doxorubicin Prodrug-Microbubble Complex with Ultrasound for Tumor Treatment
por: Luo, Wanxian, et al.
Publicado: (2017)

Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy
por: Li, Yongshuang, et al.
Publicado: (2020)

Mineralization of pH-Sensitive Doxorubicin Prodrug in ZIF-8 to Enable Targeted Delivery to Solid Tumors
por: Yan, Jiaqi, et al.
Publicado: (2020)

Dihydrodiosgenin inhibits endothelial cell-derived factor VIII and platelet-mediated hepatocellular carcinoma metastasis
por: Zhuang, Manjiao, et al.
Publicado: (2019)

Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer
por: Zhang, Yumin, et al.
Publicado: (2016)

In Vivo Protective Effects of Diosgenin against Doxorubicin-Induced Cardiotoxicity
por: Chen, Chih-Tai, et al.
Publicado: (2015)

Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy
por: Jiang, Yanhua, et al.
Publicado: (2020)

A Novel Diosgenin-Based Liposome Delivery System Combined with Doxorubicin for Liver Cancer Therapy
por: Chen, Lixia, et al.
Publicado: (2022)

Programmed Hydrolysis in Designing Paclitaxel Prodrug for Nanocarrier Assembly
por: Fu, Q., et al.
Publicado: (2015)

Magnetic Driven Nanocarriers for pH-Responsive Doxorubicin Release in Cancer Therapy
por: Nogueira, João, et al.
Publicado: (2020)

pH/redox sensitive nanoparticles with platinum(iv) prodrugs and doxorubicin enhance chemotherapy in ovarian cancer
por: Zhang, Guyu, et al.
Publicado: (2019)

Hypoxia-activated prodrugs and redox-responsive nanocarriers
por: Zeng, Yun, et al.
Publicado: (2018)

Iron-doxorubicin prodrug loaded liposome nanogenerator programs multimodal ferroptosis for efficient cancer therapy
por: Yang, Yinxian, et al.
Publicado: (2021)

pH and Reduction Dual-Responsive Nanogels as Smart Nanocarriers to Resist Doxorubicin Aggregation
por: Maruf, Ali, et al.
Publicado: (2022)

Lectin-Mediated pH-Sensitive Doxorubicin Prodrug for Pre-Targeted Chemotherapy of Colorectal Cancer with Enhanced Efficacy and Reduced Side Effects
por: Yao, Meinan, et al.
Publicado: (2019)

Diosgenin hemihydrate
por: Hernández Linares, María-Guadalupe, et al.
Publicado: (2012)

Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy
por: ZHONG, YAN-JUN, et al.
Publicado: (2012)

The design and synthesis of dextran-doxorubicin prodrug-based pH-sensitive drug delivery system for improving chemotherapy efficacy
por: Zhang, Xiaoli, et al.
Publicado: (2020)

The origin and evolution of the diosgenin biosynthetic pathway in yam
por: Cheng, Jian, et al.
Publicado: (2020)

The Equilibria of Diosgenin–Phosphatidylcholine and Diosgenin–Cholesterol in Monolayers at the Air/Water Interface
por: Janicka, Katarzyna, et al.
Publicado: (2016)

Anticancer Activity of Diosgenin and Its Molecular Mechanism
por: Ren, Qun-li, et al.
Publicado: (2023)

Simultaneous determination of doxorubicin and its dipeptide prodrug in mice plasma by HPLC with fluorescence detection()
por: Han, Jing, et al.
Publicado: (2016)

Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
por: Li, Ke, et al.
Publicado: (2019)

Targeted Delivery of Doxorubicin by Folic Acid-Decorated Dual Functional Nanocarrier
por: Lu, Jianqin, et al.
Publicado: (2014)

Spatiotemporal Control of Doxorubicin Delivery from “Stealth-Like” Prodrug Micelles
por: Kong, Li, et al.
Publicado: (2017)

Polymeric Nanocarriers: A Transformation in Doxorubicin Therapies
por: Butowska, Kamila, et al.
Publicado: (2021)

Inhibition of invadopodia formation by diosgenin in tumor cells
por: Lian, Yaxin, et al.
Publicado: (2020)

Remote loading paclitaxel–doxorubicin prodrug into liposomes for cancer combination therapy
por: Yu, Jiang, et al.
Publicado: (2020)

Synergy effects of copper ion in doxorubicin-based chelate prodrug for cancer chemo-chemodynamic combination therapy
por: Zhang, Wen, et al.
Publicado: (2023)

Correction to “Targeted Delivery of Doxorubicin by Folic Acid-Decorated Dual Functional Nanocarrier”
por: Lu, Jianqin, et al.
Publicado: (2019)

One-pot synthesis and enzyme-responsiveness of amphiphilic doxorubicin prodrug nanomicelles for cancer therapeutics
por: Han, Ling-Na, et al.
Publicado: (2022)

Trisulfide bond–mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity
por: Yang, Yinxian, et al.
Publicado: (2020)

Characterization and Biological Activities of Four Biotransformation Products of Diosgenin from Rhodococcus erythropolis
por: Li, Yanjie, et al.
Publicado: (2023)

A Nanomicellar Prodrug Carrier Based on Ibuprofen-Conjugated Polymer for Co-delivery of Doxorubicin
por: Li, Zuojun, et al.
Publicado: (2018)

Diosgenin Glucoside Protects against Spinal Cord Injury by Regulating Autophagy and Alleviating Apoptosis
por: Chen, Xian-Bing, et al.
Publicado: (2018)

Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy
por: Guo, Wei, et al.
Publicado: (2020)

Enhanced Anti-Brain Metastasis from Non-Small Cell Lung Cancer of Osimertinib and Doxorubicin Co-Delivery Targeted Nanocarrier
por: Wang, Xiaoqi, et al.
Publicado: (2020)

Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells
por: Ziganshina, Albina Y., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6qa3rcpodui23f3fhtpdvbe58q